Pharmaceutical

Novo Nordisk invests $4.1bn in manufacturing facility in NC

Novo Nordisk has unveiled a significant investment plan, committing $4.1bn to construct a second fill and finishing facility in Clayton.

Jun 26, 2024 - 04:00
Novo Nordisk invests $4.1bn in manufacturing facility in NC
Novo Nordisk has unveiled a significant investment plan, committing $4.1bn to construct a second fill and finishing facility in Clayton.
Read the original article

Tags:

Previous Article

GSK’s Omjjara gains approval in Japan for myelofibrosis treatment

Next Article

Disappointing Phase 3 Trial Results Cause Merck to Shelve Head and Neck Cancer Drug

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT+: BioMarin wins approval for gene therapy to treat hemophilia A

STAT+: BioMarin wins approval for gene therapy to treat...

Jun 30, 2023

SK pharmteco and Rznomics sign MoU to develop gene therapies

SK pharmteco and Rznomics sign MoU to develop gene ther...

Aug 7, 2024

Supreme Court votes against Purdue Pharma’s opioid settlement

Supreme Court votes against Purdue Pharma’s opioid sett...

Jun 30, 2024